MRI Contrast Agent Gadolinium May Deposit and Retain in the Brain
Briefly

Despite the widespread use of MRIs and gadolinium-based contrast agents, questions persist about the safety of injectable gadolinium, particularly regarding its retention in the body, as shown in a 2014 Japanese study.
Patients have reported adverse side effects attributed to gadolinium post-MRIs, particularly concerning for individuals with renal function issues. There is a lack of evidence on the safety for those with normal renal function or other detoxing problems.
Actor Chuck Norris filed a lawsuit related to his wife's severe health issues post-MRI involving gadolinium. The term 'gadolinium deposition disease' has been used to describe chronic health problems following contrast MRIs.
Read at Greenmedinfo
[
add
]
[
|
|
]